Sam Altman seeks investors for AI chipmaker that aims to challenge Musk-friendly Nvidia: source
Sam Altman is personally pitching OpenAI investors on backing an upstart challenger to chipmaking giant Nvidia — even as Nvidia reportedly ramps up its business ties with Elon Musk, The Post has learned.
The OpenAI CEO is promoting an upcoming $150 million second round of financing that values Rain AI — a fledgling manufacturer of high-performance semiconductors — at roughly $600 million, according to a source with direct knowledge of the situation.
Altman was a major investor in Rain AI’s 2022 $25 million seed round, sources said.
The latest round is expected to begin next month, the source said.
“He has introduced the company to all his investors for this series B round,” the source said of Altman.
Rain AI says its chips are much more energy efficient and powerful than Nvidia’s, sources said.
In June, the company hired former Apple chip executive Jean-Didier Allegrucci as head of hardware engineering.
OpenAI declined to comment.
A Rain AI spokesman didn’t immediately respond to requests for comment.
Altman is pushing Rain AI at a time his rival Elon Musk is speaking to Nvidia about investing in his xAI, The Post reported exclusively earlier this month.
Nvidia has a staggering 85% market share in the artificial intelligence chip space and has become the most valuable company in the world with a $3.5 trillion market cap.
It is expected to continue to sell its chips to Open AI even if it invests with Musk.
Still, insiders speculated that Altman has grown concerned that Nvidia’s relationship with Musk is getting too cozy.
Musk is expecting to soon spend billions to buy 100,000 Nvidia chips, CNBC reported.
“Rain AI is one of the legitimate players at the table when it comes to the future of AI and chips,” Wedbush Analyst Dan Ives told The Post.
“There’s a lot of buzz around everything Rain AI is doing and it’s the early days of the AI revolution.,” Ives added. “There’s going to be many players, not just the ‘Godfather of AI’ Jensen Huang and Nvidia.”
“When you have someone like Altman backing [them] that puts them right in the middle of Times Square with a spotlight on them,” he said.
“Any company [Altman] backs is a huge vote of confidence and gives them a massive runway to where they can head.”
Research Calls I
-
Upgrades:
- Aclaris Therapeutics (ACRS) upgraded to Buy from Hold at Jefferies; tgt raised to $7
- Aclaris Therapeutics (ACRS) upgraded to Buy from Neutral at BTIG Research; tgt $8
- Aclaris Therapeutics (ACRS) upgraded to Outperform from Market Perform at Leerink Partners; tgt raised to $7
- American Water Works (AWK) upgraded to Buy from Neutral at UBS; tgt raised to $155
- Bank of Nova Scotia (BNS) upgraded to Buy from Neutral at BofA Securities
- Bank of Nova Scotia (BNS) upgraded to Buy from Hold at Canaccord Genuity
- BioNTech (BNTX) upgraded to Outperform from In-line at Evercore ISI; tgt raised to $125
- Comfort Systems (FIX) upgraded to Buy from Neutral at UBS; tgt raised to $525
- Newmont Corporation (NEM) upgraded to Overweight from Neutral at JP Morgan
- Prada (PRDSY) upgraded to Buy from Neutral at BofA Securities
- QuantumScape Corporation (QS) upgraded to Hold from Reduce at HSBC Securities; tgt $5.30
-
Downgrades:
- Academy Sports + Outdoors (ASO) downgraded to Hold from Buy at Truist; tgt lowered to $50
- Blink Charging (BLNK) downgraded to Hold from Buy at Needham
- ChargePoint (CHPT) downgraded to Hold from Buy at Needham
- Embraer SA (ERJ) downgraded to Sell from Neutral at UBS; tgt raised to $32
- Entree Resources (EGI) downgraded to Hold from Buy at TD Securities
- Kraft Heinz (KHC) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $35
- Sabre (SABR) downgraded to Underperform from Mkt Perform at Bernstein; tgt $3
- Sea Limited (SE) downgraded to Reduce from Neutral at Phillip Securities
- Siemens AG (SIEGY) downgraded to Neutral from Buy at BofA Securities
-
Others:
- ACNB Corporation (ACNB) initiated with a Buy at Janney; tgt $53
- Apollo Global Management (APO) initiated with an Overweight at Piper Sandler; tgt $188
- Archer Aviation (ACHR) initiated with a Buy at Needham; tgt $11
- Arq, Inc. (ARQ) initiated with a Buy at Canaccord Genuity; tgt $10
- Asana (ASAN) initiated with a Sector Perform at Scotiabank; tgt $15
- aTyr Pharma (ATYR) initiated with a Buy at Lucid Capital
- Autodesk (ADSK) initiated with a Sector Outperform at Scotiabank; tgt $360
- Bank of Princeton (BPRN) initiated with a Market Perform at Hovde Group; tgt $40
- BioNTech (BNTX) initiated with a Buy at Berenberg; tgt $130
- Dayforce (DAY) initiated with a Sector Perform at Scotiabank; tgt $75
- InflaRx (IFRX) initiated with a Buy at Lucid Capital
- Intuit (INTU) initiated with a Sector Perform at Scotiabank; tgt $700
- InvenTrust Properties (IVT) initiated with a Hold at Jefferies; tgt $33
- Joby Aviation (JOBY) initiated with a Buy at Needham; tgt $8
- Moderna (MRNA) initiated with a Hold at Berenberg; tgt $42
- Monday.com (MNDY) initiated with a Sector Outperform at Scotiabank; tgt $325
- Nayax Ltd. (NYAX) initiated with a Buy at B. Riley Securities; tgt $38
- Okta (OKTA) initiated with an Equal Weight at Barclays; tgt $81
- Salesforce (CRM) initiated with a Sector Outperform at Scotiabank; tgt $425
- Septerna (SEPN) initiated with an Overweight at Cantor Fitzgerald; tgt $50
- Septerna (SEPN) initiated with an Overweight at Wells Fargo; tgt $43
- Septerna (SEPN) initiated with an Overweight at JP Morgan; tgt $38
- Septerna (SEPN) initiated with a Buy at TD Cowen
- ServiceNow (NOW) initiated with a Sector Outperform at Scotiabank; tgt $1230
- Sprinklr (CXM) initiated with a Sector Perform at Scotiabank; tgt $7.70
- Sprout Social (SPT) initiated with a Sector Perform at Scotiabank; tgt $28
- Tesco PLC (TSCDY) initiated with a Sector Perform at RBC Capital Mkts
- Veeva Systems (VEEV) initiated with a Sector Perform at Scotiabank; tgt $235
- Viavi (VIAV) initiated with a Neutral at UBS; tgt $10.60
- WeRide (WRD) initiated with an Overweight at Morgan Stanley; tgt $23
- Workday (WDAY) initiated with a Sector Outperform at Scotiabank; tgt $340
- ZoomInfo (ZI) initiated with a Sector Perform at Scotiabank; tgt $10.30
Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- GDS -3.4%, ACM -2.5% (also increases repurchase plan and dividend), LOW -2%, J -1.7%, VIPS -1.3%, OCSL -0.9%
Other news:
- INCY -11.5% (update on MRGPRX2 and MRGPRX4 programs)
- HMST -7% (HomeStreet and FirstSun Capital Bancorp (FSUN) terminate their previously announced merger agreement)
- AVAV -4.9% (will acquire BlueHalo in an all-stock transaction with an enterprise value of approximately $4.1 bln)
- DJT -4.5% (in talks to buy Bakkt (BKKT), according to FT.com)
- SYRE -4.1% (prices offering of 7.275 mln shares of common stock at $27.50 per share)
- TLSA -4.1% (announces that its grant application to the ALS Association has been approved for funding)
- LEU -4% (discloses the government of the Russian Federation passed a decree, effective through December 31, 2025, that rescinded TENEX's general license to export LEU to the United States or to entities registered in the United States)
- PTGX -3.4% (topline results from Phase 3 ICONIC studies)
- BTM -2.1% (CFO resigns; appoints acting CFO)
- IIIN -2% (closing facility in OH)
- AMCR -1.8% (Amcor & Berry Global Group (BERY) announce they have entered into a definitive merger agreement, pursuant to which Amcor and Berry will combine in an all-stock transaction)
- GSK -1.6% (reports GLISTEN trial of Linerixibat meets endpoint)
- KWR -1.3% (appoints new CEO)
Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- SYM +29.7%, WB +5.8%, ATAT +5.3%, KC +5.1%, XPEV +4.3%, TCOM +4%, WMT +4%, FINV +3.6%, AS +2.9%, ENR +1.6%, VIK +0.9%
Other news:
- SMCI +25.8% (engages BDO USA, P.C. as its independent auditor)
- FSUN +8.3% (HomeStreet and FirstSun Capital Bancorp (FSUN) terminate their previously announced merger agreement)
- BERY +4.3% (Amcor & Berry Global Group (BERY) announce they have entered into a definitive merger agreement, pursuant to which Amcor and Berry will combine in an all-stock transaction; also reported earnings)
- MSTR +3.2% (offering $1.75 bln convertible senior notes)
- MARA +3.1% (prices offering of $850 mln of 0.00% convertible senior notes due 2030)
- PLL +2.9% (Piedmont Lithium and Sayona Mining to combine in all-stock merger)
- ERII +2.7% ($50 mln repurchase plan)
- GRAL +2.4% (first patient tested in Phase 3 study)
- BWLP +2.3% (provides fleet update with sale of large gas carriers)
- VIR +1.7% (receives positive opinion on orphan drug designation for Tobevibart and Elebsiran; Presents Positive Chronic Hepatitis Delta Clinical Trial Data and Announces Initiation of Phase 3 Registrational Program)
- MCHP +1.7% (CEO to retire; appoints interim CEO)
- SEI +1.2% files $500 mln mixed shelf)
Justice Department Will Reportedly Push Google to Sell Chrome
The Department of Justice will ask a federal judge to force Google to sell its Chrome browser to address its illegal search monopoly, Bloomberg reported on Monday. The Justice Department will also ask the judge, Amit Mehta, to force Google to license its search engine data and stop bundling its Android operating system with products including search and its Google Play mobile app store, according to Bloomberg.
The Justice Department intends to ask for the Chrome sale because it is a key access point via which people use Google’s search engine, Bloomberg reported, adding that details of the remedy could still change. The Justice Department had previously flagged that it could ask for the sale of Chrome or Android as possible remedies.
In August, Mehta ruled that Google had used its exclusive distribution contracts with companies such as Apple and Samsung to create an illegal search monopoly. The Justice Department is expected to formally issue its remedies framework this week, but Mehta is not expected to issue a ruling on remedies until August 2025. Google has said it will appeal the case.
Walmart beats by $0.05, beats on revs; guides FY25 EPS in-line (84.08)
- Reports Q3 (Oct) earnings of $0.58 per share, excluding non-recurring items, $0.05 better than the FactSet Consensus of $0.53; revenues rose 5.5% year/year to $169.59 bln vs the $167.65 bln FactSet Consensus.
- Q3 Consolidated gross margin rate up 21 bps, led by Walmart U.S.
- ROA at 7.8%; ROI at 15.1%1, up 100 bps
- Global inventory down 1.0%, including a decrease of 0.6% for Walmart U.S.; in-stock levels healthy
- Co issues guidance for FY25, sees EPS of $2.42-2.47, excluding non-recurring items, vs. $2.45 FactSet Consensus; sees FY25 revs of +4.8-5.1% yr/yr to $673.5-675.4 bln, may not be comparable to $678.16 bln FactSet Consensus.
Early premarket gappers
-
Gapping up:
- SYM +29.7%, SMCI +26.4%, FSUN +8.3%, KC +6.7%, WB +5.8%, FINV +5.5%, TCOM +4.7%, BERY +4.1%, VIR +3.7%, XPEV +3.7%, PLL +2.9%, ERII +2.7%, MARA +2.7%, ATAT +2.6%, BWLP +2.3%, MDT +1.3%, SEI +1.2%, MCHP +1.2%, NWN +0.8%, LANC +0.8%, TECK +0.7%
-
Gapping down:
- INCY -12.3%, FFIC -12.2%, HMST -7.1%, DJT -6%, J -3.8%, BTM -3.6%, PTGX -3.4%, LEU -3.3%, ACM -3.3%, OCSL -2.9%, SYRE -2.3%, AVAV -2.1%, IIIN -2%, GSK -1.5%, AMCR -1.5%, KWR -1.3%, VIPS -1.3%, ADM -1.1%, FUTU -1.1%, LOW -1.1%, COHR -0.9%, CYTK -0.8%, GOOG -0.7%